Page last updated: 2024-10-25

cilostazol and Heart Diseases

cilostazol has been researched along with Heart Diseases in 2 studies

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
"Cilostazol is a potent type III phosphodiesterase inhibitor with pharmacological effects that include vasodilatation, inhibition of platelet activation and aggregation, inhibition of thrombosis, increased blood flow to the limbs, improvement in serum lipids with lowering of triglycerides and elevation of high density lipoprotein cholesterol, and inhibition of vascular smooth muscle cell growth."2.44Cilostazol in the management of vascular disease. ( Dalainas, I, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z1
Qian, J1
Chen, Y1
Ma, J1
Ge, J1
Dalainas, I1

Reviews

2 reviews available for cilostazol and Heart Diseases

ArticleYear
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:5

    Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Dise

2013
Cilostazol in the management of vascular disease.
    International angiology : a journal of the International Union of Angiology, 2007, Volume: 26, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiovascular Diseases; Cerebrovascular Disorders; Cilostazol;

2007

Trials

1 trial available for cilostazol and Heart Diseases

ArticleYear
Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:5

    Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Dise

2013